Cargando…
A comparative study to evaluate the effect of intranasal dexmedetomidine versus oral alprazolam as a premedication agent in morbidly obese patients undergoing bariatric surgery
BACKGROUND: Morbidly obese patients with obstructive sleep apnea are extremely sensitive to sedative premedication. Intranasal dexmedetomidine is painless and quick acting. Intranasal dexmedetomidine can be used for premedication as it produces adequate sedation and also obtund hemodynamic response...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713663/ https://www.ncbi.nlm.nih.gov/pubmed/23878437 http://dx.doi.org/10.4103/0970-9185.111680 |
_version_ | 1782277218823569408 |
---|---|
author | Jayaraman, Lakshmi Sinha, Aparna Punhani, Dinesh |
author_facet | Jayaraman, Lakshmi Sinha, Aparna Punhani, Dinesh |
author_sort | Jayaraman, Lakshmi |
collection | PubMed |
description | BACKGROUND: Morbidly obese patients with obstructive sleep apnea are extremely sensitive to sedative premedication. Intranasal dexmedetomidine is painless and quick acting. Intranasal dexmedetomidine can be used for premedication as it produces adequate sedation and also obtund hemodynamic response to laryngoscopy and tracheal intubation. MATERIALS AND METHODS: Forty morbidly obese patients with BMI > 35 were chosen and divided into two groups. Group DEX received intranasal dexmedetomidine 1 mcg/kg (ideal body weight) while other group (AZ) received oral alprazolam 0.5 mg. Sedation scale, heart rate and the mean arterial pressure was assessed in both the groups at 0 hour, 45 minutes, during laryngoscopy and tracheal intubation. RESULTS: The demographic profile, baseline heart rate, means arterial pressure, oxygen saturation and sedation scale was comparable between the two groups. The sedation scores, after 45 min, were statistically significant between the two groups i.e., 2.40 ± 1.09 in the AZ group as compared to 3.20 ± 1.79 in DEX group P value 0.034. The heart rate, mean arterial pressure and oxygen saturation were statistically similar between the two groups, after 45 min. The heart rate was significantly lower in the DEX group as compared to the AZ group. There was no statistical difference in the mean arterial pressure between the two groups either during laryngoscopy or tracheal intubation. CONCLUSION: Intranasal dexmedetomidine is a better premedication agent in morbidly obese patients than oral alprazolam. |
format | Online Article Text |
id | pubmed-3713663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-37136632013-07-22 A comparative study to evaluate the effect of intranasal dexmedetomidine versus oral alprazolam as a premedication agent in morbidly obese patients undergoing bariatric surgery Jayaraman, Lakshmi Sinha, Aparna Punhani, Dinesh J Anaesthesiol Clin Pharmacol Original Article BACKGROUND: Morbidly obese patients with obstructive sleep apnea are extremely sensitive to sedative premedication. Intranasal dexmedetomidine is painless and quick acting. Intranasal dexmedetomidine can be used for premedication as it produces adequate sedation and also obtund hemodynamic response to laryngoscopy and tracheal intubation. MATERIALS AND METHODS: Forty morbidly obese patients with BMI > 35 were chosen and divided into two groups. Group DEX received intranasal dexmedetomidine 1 mcg/kg (ideal body weight) while other group (AZ) received oral alprazolam 0.5 mg. Sedation scale, heart rate and the mean arterial pressure was assessed in both the groups at 0 hour, 45 minutes, during laryngoscopy and tracheal intubation. RESULTS: The demographic profile, baseline heart rate, means arterial pressure, oxygen saturation and sedation scale was comparable between the two groups. The sedation scores, after 45 min, were statistically significant between the two groups i.e., 2.40 ± 1.09 in the AZ group as compared to 3.20 ± 1.79 in DEX group P value 0.034. The heart rate, mean arterial pressure and oxygen saturation were statistically similar between the two groups, after 45 min. The heart rate was significantly lower in the DEX group as compared to the AZ group. There was no statistical difference in the mean arterial pressure between the two groups either during laryngoscopy or tracheal intubation. CONCLUSION: Intranasal dexmedetomidine is a better premedication agent in morbidly obese patients than oral alprazolam. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3713663/ /pubmed/23878437 http://dx.doi.org/10.4103/0970-9185.111680 Text en Copyright: © Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Jayaraman, Lakshmi Sinha, Aparna Punhani, Dinesh A comparative study to evaluate the effect of intranasal dexmedetomidine versus oral alprazolam as a premedication agent in morbidly obese patients undergoing bariatric surgery |
title | A comparative study to evaluate the effect of intranasal dexmedetomidine versus oral alprazolam as a premedication agent in morbidly obese patients undergoing bariatric surgery |
title_full | A comparative study to evaluate the effect of intranasal dexmedetomidine versus oral alprazolam as a premedication agent in morbidly obese patients undergoing bariatric surgery |
title_fullStr | A comparative study to evaluate the effect of intranasal dexmedetomidine versus oral alprazolam as a premedication agent in morbidly obese patients undergoing bariatric surgery |
title_full_unstemmed | A comparative study to evaluate the effect of intranasal dexmedetomidine versus oral alprazolam as a premedication agent in morbidly obese patients undergoing bariatric surgery |
title_short | A comparative study to evaluate the effect of intranasal dexmedetomidine versus oral alprazolam as a premedication agent in morbidly obese patients undergoing bariatric surgery |
title_sort | comparative study to evaluate the effect of intranasal dexmedetomidine versus oral alprazolam as a premedication agent in morbidly obese patients undergoing bariatric surgery |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713663/ https://www.ncbi.nlm.nih.gov/pubmed/23878437 http://dx.doi.org/10.4103/0970-9185.111680 |
work_keys_str_mv | AT jayaramanlakshmi acomparativestudytoevaluatetheeffectofintranasaldexmedetomidineversusoralalprazolamasapremedicationagentinmorbidlyobesepatientsundergoingbariatricsurgery AT sinhaaparna acomparativestudytoevaluatetheeffectofintranasaldexmedetomidineversusoralalprazolamasapremedicationagentinmorbidlyobesepatientsundergoingbariatricsurgery AT punhanidinesh acomparativestudytoevaluatetheeffectofintranasaldexmedetomidineversusoralalprazolamasapremedicationagentinmorbidlyobesepatientsundergoingbariatricsurgery AT jayaramanlakshmi comparativestudytoevaluatetheeffectofintranasaldexmedetomidineversusoralalprazolamasapremedicationagentinmorbidlyobesepatientsundergoingbariatricsurgery AT sinhaaparna comparativestudytoevaluatetheeffectofintranasaldexmedetomidineversusoralalprazolamasapremedicationagentinmorbidlyobesepatientsundergoingbariatricsurgery AT punhanidinesh comparativestudytoevaluatetheeffectofintranasaldexmedetomidineversusoralalprazolamasapremedicationagentinmorbidlyobesepatientsundergoingbariatricsurgery |